Case Report
BibTex RIS Cite

CD45 pozitif ve CD45 negatif neoplastik plazma hücreleri saptanan multiple miyelom olgusu

Year 2021, Volume: 14 Issue: 2, 360 - 365, 25.08.2021
https://doi.org/10.26559/mersinsbd.864232

Abstract

Multiple Miyelom (MM) kemik iliğindeki plazma hücrelerinin üretimini etkileyen bir kanser türüdür. B hücrelerinin farklılaşması sonucu oluşan, immunglobulin (antikor) üreten plazma hücreleri miyelom hücresine dönüşünce, antikor yerine monoklonal protein (M-protein) üretirler. Miyeloma hücreleri genellikle CD45 ekspresyonu göstermezler. Bu makalede akım sitometrik immünfenotipleme çalışmasında CD45(+) ve CD45(-) hücreleri birlikte taşıyan bir multiple miyelom vakası sunulmaktadır.

Supporting Institution

Yoktur

Project Number

Yoktur

References

  • 1. Ündar L. Plasma hücresi hastalıkları (Monoklonal Gammopatiler). İçinde: Çetin E, Yalçın A, eds. Hematoloji. 1. Baskı. Yenişehir, Ankara: MN Medikal & Nobel; 2008: 225-226.
  • 2. Schentrup D. Diagnosing multiple myeloma in primary care. Clinician Reviews. 2018;16-21.
  • 3. Ortolani C. Neoplastic diseases of mature B Cells. Flow cytometry of hematological malignancies. 1. Baskı. West Sussex: Wiley- Blackwell; 2011
  • 4. Rawstron AC. Immunophenotyping of plasma cells. current protocols in cytometry. https://currentprotocols.onlinelibrary.wiley.com/doi/epdf/10.1002/0471142956.cy0623s36. 2006’da basıldı. 2021’de erişildi
  • 5. Jeong TD, Park CJ, Shim H, et al. Simplified flow cytometric immunophenotyping panel for multiple myeloma, CD56/CD19/CD138(CD38)/CD45, to differentiate neoplastic myeloma cells from reactive plasma cells. The Korean Journal of Hematology. 2012;47(4):260-6. doi:10.5045/kjh.2012.47.4.260
  • 6. Gonsalves WI, Timm MM, Rajkumar SV, et al. The prognostic significance of CD45 expression by clonal bone marrow plasma cells in patients with newly diagnosed multiple myeloma. Leukemia Research. 2016;44:32-39. doi.org/10.1016/j.leukres.2016.03.003
  • 7. Kumar S, Rajkumar SV, Kimlinger T, Greipp PR, Witzig TE. CD45 expression by bone marrow plasma cells in multiple myeloma: clinical and biological correlations . Leukemia. 2005;19:1466–1470. doi:10.1038/sj.leu.2403823
  • 8. Rawstron AC, Orfao A, Beksac M, et al. On behalf of the European Myeloma Network. Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders. Haematologica. 2008;93(3):431-438. doi: 10.3324/haematol.11080

A case of multiple myeloma with CD45 positive and CD45 negative neoplastic plasma cells

Year 2021, Volume: 14 Issue: 2, 360 - 365, 25.08.2021
https://doi.org/10.26559/mersinsbd.864232

Abstract

Multiple Myeloma (MM) is a type of cancer that affects the plasma cells proliferation in the bone marrow. When plasma cells that produce immunoglobulin (antibody), which are formed as a result of differentiation of B cells, turn into myeloma cells, they produce monoclonal protein (M-protein) instead of antibody. Myeloma cells are usually detected as CD45(-). In this article, we present a case of multiple myeloma carrying CD45(+) and CD45(-) cells together in a flow cytometric immunophenotyping study.

Project Number

Yoktur

References

  • 1. Ündar L. Plasma hücresi hastalıkları (Monoklonal Gammopatiler). İçinde: Çetin E, Yalçın A, eds. Hematoloji. 1. Baskı. Yenişehir, Ankara: MN Medikal & Nobel; 2008: 225-226.
  • 2. Schentrup D. Diagnosing multiple myeloma in primary care. Clinician Reviews. 2018;16-21.
  • 3. Ortolani C. Neoplastic diseases of mature B Cells. Flow cytometry of hematological malignancies. 1. Baskı. West Sussex: Wiley- Blackwell; 2011
  • 4. Rawstron AC. Immunophenotyping of plasma cells. current protocols in cytometry. https://currentprotocols.onlinelibrary.wiley.com/doi/epdf/10.1002/0471142956.cy0623s36. 2006’da basıldı. 2021’de erişildi
  • 5. Jeong TD, Park CJ, Shim H, et al. Simplified flow cytometric immunophenotyping panel for multiple myeloma, CD56/CD19/CD138(CD38)/CD45, to differentiate neoplastic myeloma cells from reactive plasma cells. The Korean Journal of Hematology. 2012;47(4):260-6. doi:10.5045/kjh.2012.47.4.260
  • 6. Gonsalves WI, Timm MM, Rajkumar SV, et al. The prognostic significance of CD45 expression by clonal bone marrow plasma cells in patients with newly diagnosed multiple myeloma. Leukemia Research. 2016;44:32-39. doi.org/10.1016/j.leukres.2016.03.003
  • 7. Kumar S, Rajkumar SV, Kimlinger T, Greipp PR, Witzig TE. CD45 expression by bone marrow plasma cells in multiple myeloma: clinical and biological correlations . Leukemia. 2005;19:1466–1470. doi:10.1038/sj.leu.2403823
  • 8. Rawstron AC, Orfao A, Beksac M, et al. On behalf of the European Myeloma Network. Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders. Haematologica. 2008;93(3):431-438. doi: 10.3324/haematol.11080
There are 8 citations in total.

Details

Primary Language Turkish
Subjects Health Care Administration
Journal Section Articles
Authors

Oya Gezer 0000-0002-0898-3369

Cemil Gülüm 0000-0002-0535-9966

Onur Bobuşoğlu 0000-0002-2802-1108

Anıl Tombak 0000-0002-7195-1845

Mehmet Burak Çimen 0000-0002-1274-3499

Lülüfer Tamer 0000-0002-0997-0260

Project Number Yoktur
Publication Date August 25, 2021
Submission Date January 19, 2021
Acceptance Date April 5, 2021
Published in Issue Year 2021 Volume: 14 Issue: 2

Cite

APA Gezer, O., Gülüm, C., Bobuşoğlu, O., Tombak, A., et al. (2021). CD45 pozitif ve CD45 negatif neoplastik plazma hücreleri saptanan multiple miyelom olgusu. Mersin Üniversitesi Sağlık Bilimleri Dergisi, 14(2), 360-365. https://doi.org/10.26559/mersinsbd.864232
AMA Gezer O, Gülüm C, Bobuşoğlu O, Tombak A, Çimen MB, Tamer L. CD45 pozitif ve CD45 negatif neoplastik plazma hücreleri saptanan multiple miyelom olgusu. Mersin Univ Saglık Bilim derg. August 2021;14(2):360-365. doi:10.26559/mersinsbd.864232
Chicago Gezer, Oya, Cemil Gülüm, Onur Bobuşoğlu, Anıl Tombak, Mehmet Burak Çimen, and Lülüfer Tamer. “CD45 Pozitif Ve CD45 Negatif Neoplastik Plazma hücreleri Saptanan Multiple Miyelom Olgusu”. Mersin Üniversitesi Sağlık Bilimleri Dergisi 14, no. 2 (August 2021): 360-65. https://doi.org/10.26559/mersinsbd.864232.
EndNote Gezer O, Gülüm C, Bobuşoğlu O, Tombak A, Çimen MB, Tamer L (August 1, 2021) CD45 pozitif ve CD45 negatif neoplastik plazma hücreleri saptanan multiple miyelom olgusu. Mersin Üniversitesi Sağlık Bilimleri Dergisi 14 2 360–365.
IEEE O. Gezer, C. Gülüm, O. Bobuşoğlu, A. Tombak, M. B. Çimen, and L. Tamer, “CD45 pozitif ve CD45 negatif neoplastik plazma hücreleri saptanan multiple miyelom olgusu”, Mersin Univ Saglık Bilim derg, vol. 14, no. 2, pp. 360–365, 2021, doi: 10.26559/mersinsbd.864232.
ISNAD Gezer, Oya et al. “CD45 Pozitif Ve CD45 Negatif Neoplastik Plazma hücreleri Saptanan Multiple Miyelom Olgusu”. Mersin Üniversitesi Sağlık Bilimleri Dergisi 14/2 (August 2021), 360-365. https://doi.org/10.26559/mersinsbd.864232.
JAMA Gezer O, Gülüm C, Bobuşoğlu O, Tombak A, Çimen MB, Tamer L. CD45 pozitif ve CD45 negatif neoplastik plazma hücreleri saptanan multiple miyelom olgusu. Mersin Univ Saglık Bilim derg. 2021;14:360–365.
MLA Gezer, Oya et al. “CD45 Pozitif Ve CD45 Negatif Neoplastik Plazma hücreleri Saptanan Multiple Miyelom Olgusu”. Mersin Üniversitesi Sağlık Bilimleri Dergisi, vol. 14, no. 2, 2021, pp. 360-5, doi:10.26559/mersinsbd.864232.
Vancouver Gezer O, Gülüm C, Bobuşoğlu O, Tombak A, Çimen MB, Tamer L. CD45 pozitif ve CD45 negatif neoplastik plazma hücreleri saptanan multiple miyelom olgusu. Mersin Univ Saglık Bilim derg. 2021;14(2):360-5.

MEU Journal of Health Sciences Assoc was began to the publishing process in 2008 under the supervision of Assoc. Prof. Gönül Aslan, Editor-in-Chief, and affiliated to Mersin University Institute of Health Sciences. In March 2015, Prof. Dr. Caferi Tayyar Şaşmaz undertook the Editor-in Chief position and since then he has been in charge.

Publishing in three issues per year (April - August - December), it is a multisectoral refereed scientific journal. In addition to research articles, scientific articles such as reviews, case reports and letters to the editor are published in the journal. Our journal, which has been published via e-mail since its inception, has been published both online and in print. Following the Participation Agreement signed with TÜBİTAK-ULAKBİM Dergi Park in April 2015, it has started to accept and evaluate online publications.

Mersin University Journal of Health Sciences have been indexed by Turkey Citation Index since November 16, 2011.

Mersin University Journal of Health Sciences have been indexed by ULAKBIM Medical Database from the first issue of 2016.

Mersin University Journal of Health Sciences have been indexed by DOAJ since October 02, 2019.

Article Publishing Charge Policy: Our journal has adopted an open access policy and there is no fee for article application, evaluation, and publication in our journal. All the articles published in our journal can be accessed from the Archive free of charge.

154561545815459

Creative Commons Lisansı
This work is licensed with Attribution-NonCommercial 4.0 International.